What is ACTA Laboratories?
ACTA Laboratories operates as an independent laboratory, holding FDA registration, DEA licensing, and cGMP compliance. Specializing in comprehensive quality control services, its offerings span analytical chemistry, microbiology, and stability studies. With over three decades of experience, ACTA primarily serves the pharmaceutical and medical device industries, enabling clients to maintain rigorous oversight of product development and testing processes. The laboratory is recognized for its adaptability, catering to the needs of small businesses while upholding the stringent quality standards demanded by larger corporations. ACTA's consistent success in FDA inspections solidifies its reputation as a reliable outsourcing partner for critical analytical needs.
How much funding has ACTA Laboratories raised?
ACTA Laboratories has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in ACTA Laboratories
PPP
Public-Private Partnership
What's next for ACTA Laboratories?
The recent strategic investment signals a new phase of growth and development for ACTA Laboratories. This capital is likely to be deployed to enhance its service capabilities, expand its technological infrastructure, and potentially broaden its market reach within the pharmaceutical and medical device sectors. As a company with a long-standing track record and a commitment to regulatory compliance, ACTA is well-positioned to leverage this financing to further solidify its leadership in providing essential quality control services, thereby supporting innovation and product safety in its client industries.
See full ACTA Laboratories company page
